Dear Editor: Attention-deficit hyperactivity disorder (ADHD) is a common disorder affecting schoolchildren and adolescents (1, 2) . Studies conducted elsewhere (especially in the West) suggest a prevalence rate ranging from 3% to 15% among schoolchildren, although even higher figures have been reported. ADHD affects boys 3 to 10 times more than girls and is characterized by high comorbidity. Delayed diagnosis and inadequate treatment of ADHD can lead to repeated school failure, antisocial behaviour, road traffic accidents, family problems, and delinquencies. Research on ADHD from developing countries is scarce, despite the preponderance of youth in their communities. Conners' Rating Scale is a screening tool that is widely used in both community and hospital studies to detect hyperactivity, inattention, and behaviours related to ADHD (3, 4) . It has been translated into Arabic and validated (5, 6) .
We report on a study, the objective of which was to quantify the rate of hyperactivity and to examine its psychosocial and academic correlates in schoolboys in the Sultanate of Oman, a country with a youth-based population of 2 million, situated in the southeastern part of the Arab Peninsula. This is the first such study among Omani schoolboys.
During 2002, we obtained informed consent and studied 1502 schoolboys, aged 6 to 14 years, from 8 randomly selected public elementary schools in Muscat. Their teachers completed the short form of Conners' Teacher Rating Scale (CTRS) and also gave their subjective view of the pupil's behaviour regarding aggression, stealing, and lying. Pupils with a CTRS score ³ 15 were considered probable cases of ADHD. Social workers assisted in providing the children's demographic and school achievement variables. School performance was determined by results in both mathematics and Arabic, as well as by school failure(s) in previous years. Pupils whose grades were under 50% in one or both subjects were considered to be the poorly achieving group. SPSS software (7) was used for the data analysis, and the results of the chi-square test were considered significant if P £ 0.05.
Of the 1502 schoolboys, 117 (7.8%) had a CTRS score ³ 15 and were considered to represent the hyperactive group. This group exhibited aggressive, stealing, and lying behaviour more than their counter group (P < 0.001). Also, they had poor school achievement in both the first term of the current school year, as well as failure(s) in the previous year (P < 0.001). The birth order of the group exhibiting hyperactivity and the total number of their siblings did not differ significantly from the rest of the sample (P > 0.10 and P > 0.05, respectively). The paternal education of the boys showing hyperactivity was lower than that of the normoactive group (P = 0.05), while the maternal education was more or less similarly distributed in both groups (P = 0.25). This study confirms the presence of hyperactivity in Omani boys and is consistent with results of other studies in different countries. This finding is of high importance with regard to planning for primary, secondary, and tertiary prevention of this disorder in Oman. The poor school performance among the group with hyperactivity may be attributable to the disturbed cognitive functions that characterize such children (8, 9) . Because ADHD is a neurobiological (within-child) disorder, environmental factors do not play a role in its causation; however, the nature of that environment could influence its outcome, positively or negatively.
Effective Use of Olanzapine for Obsessive-Compulsive Symptoms in a Patient With Bipolar Disorder
Dear Editor: A connection between bipolar disorder (BD) and obsessive-compulsive disorder (OCD) has recently been suggested and is supported by epidemiologic and clinical data that report comorbidity rates too high to be explained by chance (1-4).
The comorbidity of BD with OCD has important prognostic and therapeutic implications. The less favourable functional outcome (4) and the observed higher rates of suicidality (2) are major concerns in these patients. Further, comorbidity poses significant problems with respect to treatment choice, since the use of antidepressants to control obsessive-compulsive symptoms can precipitate mania or rapid cycling (1) . We present the case of a patient with BD I and comorbid OCD whose obsessive-compulsive symptoms were successfully treated with olanzapine.
Case Report
Mr AB, aged 30 years, had been diagnosed 5 years previously with BD I and was being treated with topiramate 400 mg daily. Only recently did he report that he also suffered from recurrent, intrusive thoughts having sexual and aggressive content that led him to compulsive mental acts (specifically, praying). The obsessive-compulsive symptoms first appeared after the remission of his first manic episode; however, embarrassment and feelings of guilt prevented him from reporting them.
He received a diagnosis of OCD according to DSM-IV criteria. His original score on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was 20. Olanzapine 15 mg daily was added to his therapeutic regimen to treat the obsessive-compulsive symptoms. This medication was preferred over antidepressants because the latter may precipitate manic episodes. The addition of olanzapine led to clear improvement in the obsessivecompulsive symptoms over a period of 6 weeks, at the end of which time his Y-BOCS score was 6.
Discussion
The treatment of patients with comorbid BD and OCD appears rather problematic. It seems that mood stabilizers alone do not suffice to control obsessive-compulsive symptoms (5), although there have been some positive experiences with lithium (6), as well as with topiramate and lamotrigine (1) . The use of antidepressants risks inducing mania or rapid cycling (1), and treatment of mania with classic neuroleptic drugs may lead to worsened obsessive-compulsive symptoms (3). However, there seems to be some hope in the use of the newer, atypical antipsychotic agents. The role of these drugs in treating BD is now well established (7), and there is some evidence that such agents are efficacious in treating OCD. Most reports concern cases of refractory OCD (8-10), but it has been suggested that such cases could imply bipolarity (5).
Owing to the prognostic and therapeutic implications mentioned, it is most important to carefully assess BD patients for the existence of obsessive-compulsive symptoms. It should be borne in mind that specifically oriented questioning is necessary to disclose such symptoms, given that patients often conceal them out of ignorance or embarrassment (4) , as in the case we report. Atypical antipsychotics such as olanzapine act favourably on obsessive-compulsive symptoms, as well as on BD, and could thus be of use in patients with comorbid BD and OCD.
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Monoamine Oxidase Inhibitors and Subarachnoid Hemorrhage
Dear Editor: Hypertensive crisis with monoamine oxidase inhibitor (MAOI) use has been reported in the literature and carries an overall risk of less than 1% (1). The reported reactions were triggered by diet noncompliance or by the use of concomitant medications. Specific agents responsible for these crises include tricyclic antidepressants (TCAs), meperidine, levodopa, and hay fever and cold remedies (2-4). However, spontaneous hypertensive reactions have also been described (1). Here, we present the first case of a subarachnoid hemorrhage (SAH) observed over the last 35 years that was likely caused by a hypertensive crisis secondary to MAOI use (5).
Case Report
A man, aged 52 years, with a long-standing history of treatment-refractory atypical depression presented to hospital complaining of a severe headache. The patient's medical history did not suggest any risk factors for SAH. Five weeks prior to admission, he had begun taking oral tranylcypromine with a dosage escalating to 20 mg daily. One week after starting this medication, he complained of the "worst headache of [his] life" after consuming a meal of chicken teriyaki that included a half-tablespoon of soy sauce. When he presented at a local emergency room, his blood pressure was elevated to a systolic pressure of 210 mmHg. A noncontrast CT scan was performed. The scan revealed 2 small, hyperdense foci in the left frontal lobe and left lateral occipital lobe, with surrounding edema, consistent with an SAH. There was no evidence of hydrocephalus. His GCS score was found to be 13 to 14, and we were consulted in regard to delirium. The patient was unable to follow commands and, interestingly, had evidence of perseveration. Routine investigations were normal. A cerebral angiogram showed no evidence of aneurysm or vascular malformation and only showed vasospastic changes along branches of the left middle cerebral artery. An investigation for vasculitis was also negative.
His delirium was left untreated so that his level of consciousness could be accurately followed. The tranylcypromine and a neuroleptic for the treatment of delirium were withheld owing to concerns on the part of the neurosurgery service. The delirium resolved, and he was discharged after 17 days.
On follow-up, the patient opted for no further treatment with medication and was offered a trial of interpersonal therapy. He relied upon Tylenol 3 to manage his headache symptoms, which dissipated over time.
Discussion
Multiple factors led to the conclusion that this SAH was triggered by MAOI use. The patient's consumption of soy sauce, a recent increase in tranylcypromine dosage, ingestion of tranylcypromine close to mealtime, and a medical history devoid of SAH risk factors all suggest that MAOI use was a precipitating factor. Further, negative angiography and a laboratory workup helped rule out other possible causes. It is interesting to note that the patient's outpatient psychiatrist considered treating his depression with a TCA, which has been cited to precipitate SAH in some patients (4) . MAOI agents can be effective antidepressants, but as this case highlights, physicians and patients should be aware of their propensity to cause SAH.
